Six Analysts Turn Bullish on Salesforce, Signaling Major Re
Salesforce (CRM) saw six firms raise price targets to $300 after its Dreamforce Investor Day, citing strong AIforce growth and raised FY27 revenue guidance to $46.4B. CRM trades at 15x forward earnings, a discount to peers, with 36 upward EPS revisions in 30 days.
How this was made

The 30-second read
Why it matters
The guidance raise and ARR surge provide fresh bullish catalysts, likely supporting a rally toward higher valuation multiples.
Market read
Salesforce's updated outlook may drive broader sector optimism for AI‑focused SaaS firms.
What to watch
Potential macro headwinds or slower enterprise spending could limit growth despite guidance raise.
Background
Analyst consensus lifted price targets after Salesforce's Dreamforce Investor Day, highlighting AI-driven revenue opportunities.
Ticker impact
Salesforce reported Q2 FY27 revenue of $11.35B and raised full-year FY27 revenue guidance to $46.10‑$46.40B after Dreamforce Investor Day.
Potential price appreciation toward $300 target in the coming weeks.
Large-cap software with 240% ARR growth and multiple analysts increasing price targets indicates strong market conviction.
Market effects
Positive signal for enterprise software and AI‑enabled SaaS providers.
U.S. tech sector may see uplift as Salesforce leads AI adoption narrative.
Reinforces global AI investment trends, potentially boosting related stocks worldwide.
Counterpoint
Execution risk on Agentforce adoption and integration could temper upside.
Key entities
- CompanySalesforce
Enterprise software giant (NYSE:CRM) reporting strong Q2 results and guidance raise.



